Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Sanofi
01 1IGEPAL CA 630 SPECIAL (OCTOXYNOL-9)
02 1IGEPAL CA-630G (OCTOXYNOL 9)
03 1IGEPAL CO 887 (SAME AS IGEPAL 880) CONTRLS & TOXICITY
01 3France
01 3Inactive
01 3Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 404
Submission : 1960-10-27
Status : Inactive
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12303
Submission : 1996-12-16
Status : Inactive
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6266
Submission : 1986-04-11
Status : Inactive
Type : II
90
PharmaCompass offers a list of Octoxynol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Octoxynol manufacturer or Octoxynol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Octoxynol manufacturer or Octoxynol supplier.
PharmaCompass also assists you with knowing the Octoxynol API Price utilized in the formulation of products. Octoxynol API Price is not always fixed or binding as the Octoxynol Price is obtained through a variety of data sources. The Octoxynol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Igepal CA-630 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Igepal CA-630, including repackagers and relabelers. The FDA regulates Igepal CA-630 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Igepal CA-630 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Igepal CA-630 supplier is an individual or a company that provides Igepal CA-630 active pharmaceutical ingredient (API) or Igepal CA-630 finished formulations upon request. The Igepal CA-630 suppliers may include Igepal CA-630 API manufacturers, exporters, distributors and traders.
click here to find a list of Igepal CA-630 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Igepal CA-630 DMF (Drug Master File) is a document detailing the whole manufacturing process of Igepal CA-630 active pharmaceutical ingredient (API) in detail. Different forms of Igepal CA-630 DMFs exist exist since differing nations have different regulations, such as Igepal CA-630 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Igepal CA-630 DMF submitted to regulatory agencies in the US is known as a USDMF. Igepal CA-630 USDMF includes data on Igepal CA-630's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Igepal CA-630 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Igepal CA-630 suppliers with USDMF on PharmaCompass.
